For several years we have supported the orphanages in Grand Popo by donating food, medicine and other supplies to improve the situation of the children. The corona pandemic has resulted in a shortage of food supplies in the orphanages in Grand Popo as the traditional donors have not had the financial means during the pandemic. […]
During the pandemic, Scandinavian Biopharma has succeeded in completing and starting several clinical studies, developed an improved formulation for commercial launch and built production capacity together with our contract manufacturers. During the pandemic, the company has hired many new employees in research, clinical development, registration, manufacturing and sales. We continue to grow to achieve our […]
Scandinavian Biopharma has strengthened its vaccine portfolio through the addition of an innovative preclinical technology for the development of a new Campylobacter jejuni vaccine. Campylobacter jejuni is one of the most common causes of bacterial diarrhoeal illness in humans. Common sources of Campylobacter jejuni include raw or undercooked poultry, raw milk, raw vegetables, shellfish and […]
An improved user-friendly formulation of the world’s most advanced ETEC vaccine candidate, ETVAX®, has been developed to meet commercial requirements. We want to ensure that the new formulation gives rise to immune responses that are not inferior to the previous formulation of the vaccine that underwent earlier testing. This is done in a phase II double-blinded, […]
Scandinavian Biopharma continues to grow and welcome new colleagues. We are now further strengthening our organisation in manufacturing and are pleased to welcome Aino Råberg as our Drug Substance Lead. Aino has extensive experience from production in the pharmaceutical and life science industry and most recently came from a consulting position where she had various […]
Despite the world’s need to focus on COVID-19, diarrheal disease has not gone away. Children are still dying and facing long-term health consequences due to this preventable illness, and new interventions are still urgently needed. The Vaccines Against Shigella and ETEC (VASE) Conference, on September 28 & 30, will provide key updates on vaccines being developed for Shigella, […]
